Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 116.50
Bid: 115.00
Ask: 118.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.609%)
Open: 116.50
High: 116.50
Low: 116.50
Prev. Close: 116.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Options

21 Dec 2020 07:00

RNS Number : 2472J
Transense Technologies PLC
21 December 2020
 

 

Transense Technologies plc

("Transense", or "the Company")

 

Issue of Options

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that, further to the announcement of 13 August 2019 regarding the grant of 170,000 options to Melvyn Segal, Chief Financial Officer of the Company, these options were, on 18 December 2020, cancelled and re-granted on the same terms for administrative reasons in connection with the Company's EMI share option scheme.

 

As per the original grant, these options provide the right to subscribe for 170,000 new ordinary shares of 10 pence each at an exercise price of £0.75 per share, subject to vesting on 13 August 2021 (being two years after original grant date) and the Company's share price reaching £2.00. These options expire on 13 August 2029.

 

The FCA notification in respect of the above, made in accordance with the requirements of the EU Market Abuse Regulation, is appended below.

 

 

For further information please visit www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/James Reeve (Corporate Finance)

Tony Quirke (Equity Sales)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.

 

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

 

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Melvyn Segal

2

 

Reason for the notification

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Options to subscribe for ordinary shares of 10 pence each

 

 

Identification code

GB00BDHDTH21

 

 

b)

 

Nature of the transaction 

 

Cancellation and grant of options

c)

Price and volume

Exercise Price(s)

Volume(s)

75p

170,000

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

As above

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

18 December 2020

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFIDFFLALII
Date   Source Headline
29th Jun 20124:20 pmRNSPlacing to raise £1.756 million
29th Jun 20127:00 amRNSTotal Voting Rights
25th Jun 20127:00 amRNSMichelin uses iProbe in new 'communicating' tyres
22nd Jun 201211:05 amRNSTranslogik further order from EDP
15th Jun 201210:47 amRNSStrategic Distribution Agreement in Saudi Arabia
12th Jun 20127:00 amRNSStrategic Distribution Agreement in Malaysia
11th Jun 20127:00 amRNSAppointment of Group Executive Finance Director
6th Jun 20124:41 pmRNSExercise of Warrants
31st May 201210:53 amRNSTotal Voting Rights
31st May 20127:00 amRNSiTrack success in southern Africa
29th May 20127:00 amRNSChinese partner places order worth over USD 500k
17th May 20127:00 amRNSFirst IntelliSAW customer in India
1st May 20122:23 pmRNSExercise of Warrants
11th Apr 20127:00 amRNSIntelliSAW confirmed orders of USD 550k
4th Apr 20127:00 amRNSBridgestone Brazil Update
23rd Mar 20127:00 amRNSExclusive Distribution Agreement for India
5th Mar 20124:30 pmRNSHolding(s) in Company
28th Feb 20127:00 amRNSIntelliSAW US Representative Agreement
23rd Feb 20127:00 amRNSTranslogik order from EDP for Michelin Euromaster
6th Feb 20127:00 amRNSBridgestone Brazil order for iProbe
3rd Feb 201212:46 pmRNSReplacement - Change of Adviser
1st Feb 20127:00 amRNSChange of Adviser
17th Jan 20127:00 amRNSIntelliSAW Volume Production Shipments
30th Dec 20117:00 amRNSTotal Voting Rights
28th Dec 201112:25 pmRNSHolding(s) in Company
23rd Dec 20119:01 amRNSChange of status to executive director and award
21st Dec 20112:00 pmRNSResult of Fundraising
13th Dec 20119:34 amRNSExtension of offer period
12th Dec 20117:00 amRNSExclusive Distribution Agreement in Brazil
8th Dec 20117:00 amRNSStrategic Partnership in China
7th Dec 20117:00 amRNSStrategic Partnership
23rd Nov 20117:00 amRNSOtraco iTrack Trial
21st Nov 201110:00 amRNSProposed Fundraising - Replacement
21st Nov 20117:00 amRNSProposed Fundraising
20th Oct 20117:00 amRNSContract - Pirelli Brazil
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSNew Trading Division
27th Sep 20117:00 amRNSShare Allotment
26th Sep 20117:00 amRNSUpdate
16th Sep 20118:38 amRNSDirector/PDMR Shareholding
16th Aug 201111:32 amRNSJoint Development Agreement - McLaren Electronics
23rd Jun 20092:48 pmRNSDirector/PDMR Shareholding
8th Jun 20097:00 amRNSRe Translogik Limited
29th Apr 20091:08 pmRNSJt Development with McLaren Electronic Systems Ltd
7th Apr 20097:00 amRNSFinal Results
6th Mar 200911:18 amRNSNotice of Preliminary Results
4th Feb 20095:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20092:50 pmRNSGrant of Options
30th Jan 20092:37 pmRNSDirectorate Change
30th Jan 20091:47 pmRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.